Lantz Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$504K Buy
4,874
+85
+2% +$7.59K 0.09% 179
2026
Q1
$344K Sell
4,789
-44
-0.9% -$3.39K 0.07% 198
2025
Q4
$384K Buy
4,833
+141
+3% +$11.1K 0.08% 187
2025
Q3
$354K Buy
4,692
+1,188
+34% +$81.4K 0.08% 191
2025
Q2
$242K Buy
3,504
+113
+3% +$7.41K 0.06% 207
2025
Q1
$230K Buy
+3,391
New +$203K 0.06% 196
2024
Q1
Sell
-2,912
Closed -$230K 208
2023
Q4
$230K Buy
+2,912
New +$207K 0.08% 182

Other funds holding CVS

Lantz Financial's CVS Position: Q2 2026 in Review

Lantz Financial increased its CVS Health (CVS) stake by 1.8% in Q2 2026, buying an estimated $7.59K and bringing the position to 4,874 shares worth $504K. The position accounts for 0.09% of the portfolio, ranked #179.

Lantz Financial first reported a position in CVS in Q4 2023 and has held it in 7 quarters since. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Lantz Financial held 4,874 shares of CVS Health worth $504K as of Q2 2026.
  • Lantz Financial bought 85 CVS Health shares in Q2 2026, an estimated $7.59K.
  • CVS Health made up 0.09% of Lantz Financial's portfolio in Q2 2026, its #179 holding.
  • Lantz Financial first reported a position in CVS Health in Q4 2023 and has held it in 7 quarters since.
  • 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.